Paratek Pharmaceuticals Announces Initiation of Phase 2b Study in Nontuberculous Mycobacterial (NTM) Pulmonary Disease Caused by Mycobacterium abscessus Complex (MABc) with NUZYRA® (omadacycline)

Brenda Snow
Authentic Patient Voice

Frank Burrell
Scientific Storytelling

Matt Turner
Patient Affordability

Suma Ramadas, PhD
Medical Affairs

Liz Kane
Impactful Strategy

Stacey Gandler
Brand Nourishment

Paul Theisen
Patient Acquisition

David Linetsky
Point-of-Care Marketing

Amy Giles
Increasing Engagement

Daniel Sontupe
Market Access

Joey Cohen
Medication Adherence

Pat Purcell
Meeting Engagement

Matthew Durham
Omnidynamic Marketing

Bud Bilanich
Success Coach